Product
Fludarabine-based chemotherapy + CAR-T-CD19 Cells
1 clinical trial
5 indications
Indication
Diffuse Large B-Cell LymphomaIndication
Burkitt lymphomaIndication
Follicular LymphomaIndication
Chronic Lymphocytic LeukemiaIndication
mantle cell lymphomaClinical trial
Efficacy and Safety of Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma：a Single-center, Open-label, Pragmatic Clinical TrialStatus: Recruiting, Estimated PCD: 2023-10-13